» Articles » PMID: 20028212

P53+/mdm2- Atypical Lipomatous Tumor/well-differentiated Liposarcoma in Young Children: an Early Expression of Li-Fraumeni Syndrome

Overview
Date 2009 Dec 24
PMID 20028212
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The spectrum of lipomatous tumors differs in the adult and pediatric populations, with liposarcoma being rare in children. Nearly 10% of individuals with Li-Fraumeni syndrome develop sarcomas in the first 2 decades of life; however, the frequency of sarcoma types and subtypes in this syndrome is unknown. Two atypical lipomatous tumors/well-differentiated liposarcomas (ALT/WDLS) were identified in the pathology files of our institution in young children from "classical" Li-Fraumeni and Li-Fraumeni variant kindreds with a known germline TP53 mutation (Y220C) in one of the families. The patients were 5 and 6 years of age and the ALT/WDLSs were the first expression of the syndrome. The tumors had a high degree of cellular atypia and differed from sporadic ALT/WDLS by strong nuclear immunoreactivity for p53 and absent mdm2 expression. This is the first report of 2 ALT/WDLSs presenting in children before 10 years of age, both in association with Li-Fraumeni syndrome/variant. ALT/WDLS in a young child should raise the possibility of a cancer predisposition syndrome and, in this setting, the p53(+)/mdm2(-) immunophenotype might be characteristic. Recognition of this lesion and its association is important for early diagnosis and subsequent tumor surveillance in the proband and affected family members.

Citing Articles

Case report: Atypical lipomatous tumor of the thigh in a four-year-old girl.

Ogawa I, Hakozaki M, Kaneuchi Y, Suzuki T, Nikaido T, Yamada S Front Oncol. 2024; 14:1401861.

PMID: 39109289 PMC: 11300325. DOI: 10.3389/fonc.2024.1401861.


Comprehensive genomic profiling of a unique liposarcoma arising in a patient with Li-Fraumeni syndrome and the novel detection of c-myc amplification: a case report.

Watanabe H, Fujishima F, Motoi T, Aoyama Y, Niihori T, Takahashi M Diagn Pathol. 2022; 17(1):93.

PMID: 36514176 PMC: 9746193. DOI: 10.1186/s13000-022-01264-x.


Update of Pediatric Lipomatous Lesions: A Clinicopathological, Immunohistochemical and Molecular Overview.

Ameloot E, Cordier F, Van Dorpe J, Creytens D J Clin Med. 2022; 11(7).

PMID: 35407546 PMC: 8999862. DOI: 10.3390/jcm11071938.


Well-differentiated lipomatous neoplasms with p53 alterations: a clinicopathological and molecular study of eight cases with features of atypical pleomorphic lipomatous tumour.

Hammer P, Kunder C, Howitt B, Charville G Histopathology. 2021; 80(4):656-664.

PMID: 34725851 PMC: 8860877. DOI: 10.1111/his.14593.


MDM2 Amplified Sarcomas: A Literature Review.

Sciot R Diagnostics (Basel). 2021; 11(3).

PMID: 33799733 PMC: 8001728. DOI: 10.3390/diagnostics11030496.